Purified human basophils and mast cells: current concepts of mediator release.

E. S. Schulman, Donald Macglashan, R. P. Schleimer, S. P. Peters, A. Kagey-Sobotka, H. H. Newball, L. M. Lichtenstein

Research output: Contribution to journalArticle

Abstract

Mediators released from human basophils and mast cells in response to immunologic and other stimuli are felt to be important in the pathophysiology of several nasal and pulmonary disease processes. Recently, we have developed techniques to purify these cells, thus allowing precise ultrastructural, biochemical and pharmacological studies of mediator release. Previous literature has emphasized the similarities of the two cell types including their metachromatic staining and IgE-mediated release of mediators. However, we now appreciate that several differences exist between the two cell types. At the ultrastructural level, basophil release is characterized by individual granules emptying to the cell exterior, while mast cell granules fuse intracellularly and release their contents through cytoplasmic channels. Functionally, basophils are 10- to 30-fold more sensitive than mast cells to anti-IgE, but the kinetics of release are less rapid. Basophil, but not mast cell, release is (I) inhibited by histamine H2 agonists and glucocorticoids; (II) enhanced by PgD2 and (III) modulated by arachidonic acid lipoxygenase metabolites. Significant quantities of slow-reacting substance of anaphylaxis, PgD2 and platelet-activating factor are generated by mast cells. Basophils produce little or none of these mediators. Studies with these purified, relevant human cell types should provide important insights into the cellular basis of hypersensitivity states and their control.

Original languageEnglish (US)
JournalEuropean journal of respiratory diseases. Supplement
Volume128
StatePublished - 1983
Externally publishedYes

Fingerprint

Basophils
Mast Cells
SRS-A
Arachidonate Lipoxygenases
Nose Diseases
Histamine Agonists
Platelet Activating Factor
Immunoglobulin E
Glucocorticoids
Lung Diseases
Hypersensitivity
Pharmacology
Staining and Labeling

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Schulman, E. S., Macglashan, D., Schleimer, R. P., Peters, S. P., Kagey-Sobotka, A., Newball, H. H., & Lichtenstein, L. M. (1983). Purified human basophils and mast cells: current concepts of mediator release. European journal of respiratory diseases. Supplement, 128.

Purified human basophils and mast cells : current concepts of mediator release. / Schulman, E. S.; Macglashan, Donald; Schleimer, R. P.; Peters, S. P.; Kagey-Sobotka, A.; Newball, H. H.; Lichtenstein, L. M.

In: European journal of respiratory diseases. Supplement, Vol. 128, 1983.

Research output: Contribution to journalArticle

Schulman, ES, Macglashan, D, Schleimer, RP, Peters, SP, Kagey-Sobotka, A, Newball, HH & Lichtenstein, LM 1983, 'Purified human basophils and mast cells: current concepts of mediator release.', European journal of respiratory diseases. Supplement, vol. 128.
Schulman, E. S. ; Macglashan, Donald ; Schleimer, R. P. ; Peters, S. P. ; Kagey-Sobotka, A. ; Newball, H. H. ; Lichtenstein, L. M. / Purified human basophils and mast cells : current concepts of mediator release. In: European journal of respiratory diseases. Supplement. 1983 ; Vol. 128.
@article{5620d0a3ebc345c8874ccf7c0b96b01a,
title = "Purified human basophils and mast cells: current concepts of mediator release.",
abstract = "Mediators released from human basophils and mast cells in response to immunologic and other stimuli are felt to be important in the pathophysiology of several nasal and pulmonary disease processes. Recently, we have developed techniques to purify these cells, thus allowing precise ultrastructural, biochemical and pharmacological studies of mediator release. Previous literature has emphasized the similarities of the two cell types including their metachromatic staining and IgE-mediated release of mediators. However, we now appreciate that several differences exist between the two cell types. At the ultrastructural level, basophil release is characterized by individual granules emptying to the cell exterior, while mast cell granules fuse intracellularly and release their contents through cytoplasmic channels. Functionally, basophils are 10- to 30-fold more sensitive than mast cells to anti-IgE, but the kinetics of release are less rapid. Basophil, but not mast cell, release is (I) inhibited by histamine H2 agonists and glucocorticoids; (II) enhanced by PgD2 and (III) modulated by arachidonic acid lipoxygenase metabolites. Significant quantities of slow-reacting substance of anaphylaxis, PgD2 and platelet-activating factor are generated by mast cells. Basophils produce little or none of these mediators. Studies with these purified, relevant human cell types should provide important insights into the cellular basis of hypersensitivity states and their control.",
author = "Schulman, {E. S.} and Donald Macglashan and Schleimer, {R. P.} and Peters, {S. P.} and A. Kagey-Sobotka and Newball, {H. H.} and Lichtenstein, {L. M.}",
year = "1983",
language = "English (US)",
volume = "128",
journal = "European journal of respiratory diseases. Supplement",
issn = "0106-4347",
publisher = "Copenhagen Munksgaard International Publishers",

}

TY - JOUR

T1 - Purified human basophils and mast cells

T2 - current concepts of mediator release.

AU - Schulman, E. S.

AU - Macglashan, Donald

AU - Schleimer, R. P.

AU - Peters, S. P.

AU - Kagey-Sobotka, A.

AU - Newball, H. H.

AU - Lichtenstein, L. M.

PY - 1983

Y1 - 1983

N2 - Mediators released from human basophils and mast cells in response to immunologic and other stimuli are felt to be important in the pathophysiology of several nasal and pulmonary disease processes. Recently, we have developed techniques to purify these cells, thus allowing precise ultrastructural, biochemical and pharmacological studies of mediator release. Previous literature has emphasized the similarities of the two cell types including their metachromatic staining and IgE-mediated release of mediators. However, we now appreciate that several differences exist between the two cell types. At the ultrastructural level, basophil release is characterized by individual granules emptying to the cell exterior, while mast cell granules fuse intracellularly and release their contents through cytoplasmic channels. Functionally, basophils are 10- to 30-fold more sensitive than mast cells to anti-IgE, but the kinetics of release are less rapid. Basophil, but not mast cell, release is (I) inhibited by histamine H2 agonists and glucocorticoids; (II) enhanced by PgD2 and (III) modulated by arachidonic acid lipoxygenase metabolites. Significant quantities of slow-reacting substance of anaphylaxis, PgD2 and platelet-activating factor are generated by mast cells. Basophils produce little or none of these mediators. Studies with these purified, relevant human cell types should provide important insights into the cellular basis of hypersensitivity states and their control.

AB - Mediators released from human basophils and mast cells in response to immunologic and other stimuli are felt to be important in the pathophysiology of several nasal and pulmonary disease processes. Recently, we have developed techniques to purify these cells, thus allowing precise ultrastructural, biochemical and pharmacological studies of mediator release. Previous literature has emphasized the similarities of the two cell types including their metachromatic staining and IgE-mediated release of mediators. However, we now appreciate that several differences exist between the two cell types. At the ultrastructural level, basophil release is characterized by individual granules emptying to the cell exterior, while mast cell granules fuse intracellularly and release their contents through cytoplasmic channels. Functionally, basophils are 10- to 30-fold more sensitive than mast cells to anti-IgE, but the kinetics of release are less rapid. Basophil, but not mast cell, release is (I) inhibited by histamine H2 agonists and glucocorticoids; (II) enhanced by PgD2 and (III) modulated by arachidonic acid lipoxygenase metabolites. Significant quantities of slow-reacting substance of anaphylaxis, PgD2 and platelet-activating factor are generated by mast cells. Basophils produce little or none of these mediators. Studies with these purified, relevant human cell types should provide important insights into the cellular basis of hypersensitivity states and their control.

UR - http://www.scopus.com/inward/record.url?scp=0020671122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020671122&partnerID=8YFLogxK

M3 - Article

C2 - 6578086

AN - SCOPUS:0020671122

VL - 128

JO - European journal of respiratory diseases. Supplement

JF - European journal of respiratory diseases. Supplement

SN - 0106-4347

ER -